- Marlborough MA, US Christopher ELZINGA - San Juan Capistrano CA, US Glenn MASTON - San Juan Capistrano CA, US Joseph HIGGINS - San Juan Capistrano CA, US Sat DEV BATISH - San Juan Capistrano CA, US Christina DIVINCENZO - San Juan Capistrano CA, US Michele MCCARTHY - San Juan Capistrano CA, US Jennifer LAPIERRE - San Juan Capistrano CA, US Felicita DUBOIS - San Juan Capistrano CA, US Katelyn MEDEIROS - San Juan Capistrano CA, US Jeffery JONES - San Juan Capistrano CA, US Corey BRAASTAD - San Juan Capistrano CA, US
Assignee:
Athena Diagnostics, Inc. - Marlborough MA
International Classification:
G16B 20/00
Abstract:
Provided are methods and systems for determining the clinical significance of a genetic variant. The methods entail determining, for the variant, (a) a function score based on known impact of the variant on a biological function of a cell or protein, (b) a frequency score based on the frequency of the variant in a population, (c) a co-occurrence score based on how the variant co-occurs with a reference variant having known clinical significance relating to a clinical disease or condition, and (d) a family segregation score based on how the variant segregates with a disease or condition in a family; and aggregating, on a computer, the function score, the frequency score, the co-occurrence score, the family segregation score to generate a clinical significance score indicating the clinical significance of the genetic variant.
Pathogenicity Scoring System For Human Clinical Genetics
- SanJuan Capistrano CA, US Christopher ELZINGA - San Juan Capistrano CA, US Glenn MASTON - San Juan Capistrano CA, US Joseph HIGGINS - San Juan Capistrano CA, US Sat DEV BATISH - San Juan Capistrano CA, US Christina DIVINCENZO - San Juan Capistrano CA, US Michele MCCARTHY - San Juan Capistrano CA, US Jennifer LAPIERRE - San Juan Capistrano CA, US Felicita DUBOIS - San Juan Capistrano CA, US Katelyn MEDEIROS - San Juan Capistrano CA, US Jeffery JONES - San Juan Capistrano CA, US Corey BRAASTAD - San Juan Capistrano CA, US
Assignee:
Athena Diagnostics, Inc. - Marlborough MA
International Classification:
G06F 19/18
Abstract:
Provided are methods and systems for determining the clinical significance of a genetic variant. The methods entail determining, for the variant, (a) a function score based on known impact of the variant on a biological function of a cell or protein, (b) a frequency score based on the frequency of the variant in a population, (c) a co-occurrence score based on how the variant co-occurs with a reference variant having known clinical significance relating to a clinical disease or condition, and (d) a family segregation score based on how the variant segregates with a disease or condition in a family; and aggregating, on a computer, the function score, the frequency score, the co-occurrence score, the family segregation score to generate a clinical significance score indicating the clinical significance of the genetic variant.
Bill Stallings, Shannon Strunk, John Taylor, Ann Munsell, Lisa Strunk, Kelly Bornmueller, Don Merz, William Sansone, Dave Moran, Cheryl Braun, Chris Lafata, Christine Pelker